AXSM logo

Axsome Therapeutics (AXSM) Selling, general & administrative expenses

annual SGA:

$411.36M+$88.24M(+27.31%)
December 31, 2024

Summary

  • As of today (May 30, 2025), AXSM annual SGA is $411.36 million, with the most recent change of +$88.24 million (+27.31%) on December 31, 2024.
  • During the last 3 years, AXSM annual SGA has risen by +$344.71 million (+517.23%).
  • AXSM annual SGA is now at all-time high.

Performance

AXSM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMincome statement metrics

quarterly SGA:

$120.79M+$7.52M(+6.64%)
March 31, 2025

Summary

  • As of today (May 30, 2025), AXSM quarterly SGA is $120.79 million, with the most recent change of +$7.52 million (+6.64%) on March 31, 2025.
  • Over the past year, AXSM quarterly SGA has increased by +$21.82 million (+22.04%).
  • AXSM quarterly SGA is now at all-time high.

Performance

AXSM quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMincome statement metrics

TTM SGA:

-$4.34B-$278.27M(-6.86%)
March 31, 2025

Summary

  • As of today (May 30, 2025), AXSM TTM SGA is -$4.34 billion, with the most recent change of -$278.27 million (-6.86%) on March 31, 2025.
  • Over the past year, AXSM TTM SGA has dropped by -$4.68 billion (-1346.37%).
  • AXSM TTM SGA is now -52592.06% below its all-time high of -$8.23 million.

Performance

AXSM TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AXSM Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.3%+22.0%-1346.4%
3 y3 years+517.2%+369.9%-5446.5%
5 y5 years+2925.1%+2330.3%-10000.0%

AXSM Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+517.2%at high+369.9%-175.6%at low
5 y5-yearat high+2925.1%at high+2330.3%-549.8%at low
alltimeall timeat high>+9999.0%at high>+9999.0%<-9999.0%at low

AXSM Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$120.79M(+6.6%)
$433.18M(+5.3%)
Dec 2024
$411.36M(+27.3%)
$113.27M(+18.5%)
$411.36M(+6.9%)
Sep 2024
-
$95.56M(-7.7%)
$384.90M(+3.3%)
Jun 2024
-
$103.55M(+4.6%)
$372.52M(+7.1%)
Mar 2024
-
$98.97M(+14.0%)
$347.90M(+7.7%)
Dec 2023
$323.12M(+102.9%)
$86.81M(+4.4%)
$323.12M(+8.5%)
Sep 2023
-
$83.19M(+5.4%)
$297.81M(+16.6%)
Jun 2023
-
$78.94M(+6.4%)
$255.52M(+23.0%)
Mar 2023
-
$74.19M(+20.6%)
$207.74M(+30.4%)
Dec 2022
$159.25M(+139.0%)
$61.50M(+50.4%)
$159.25M(+36.6%)
Sep 2022
-
$40.89M(+31.2%)
$116.58M(+21.5%)
Jun 2022
-
$31.16M(+21.2%)
$95.92M(+18.3%)
Mar 2022
-
$25.70M(+36.5%)
$81.10M(+21.7%)
Dec 2021
$66.65M(+130.6%)
$18.83M(-6.9%)
$66.65M(+14.6%)
Sep 2021
-
$20.23M(+23.8%)
$58.18M(+31.4%)
Jun 2021
-
$16.34M(+45.3%)
$44.28M(+25.9%)
Mar 2021
-
$11.25M(+8.6%)
$35.18M(+21.7%)
Dec 2020
$28.90M(+112.5%)
$10.36M(+63.6%)
$28.90M(+21.6%)
Sep 2020
-
$6.33M(-12.5%)
$23.76M(+15.7%)
Jun 2020
-
$7.24M(+45.6%)
$20.54M(+30.4%)
Mar 2020
-
$4.97M(-4.8%)
$15.75M(+15.8%)
Dec 2019
$13.60M
$5.22M(+67.8%)
$13.60M(+27.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
$3.11M(+27.3%)
$10.67M(+9.3%)
Jun 2019
-
$2.45M(-13.2%)
$9.77M(+0.1%)
Mar 2019
-
$2.82M(+22.6%)
$9.76M(+4.4%)
Dec 2018
$9.35M(+29.8%)
$2.30M(+4.4%)
$9.35M(+3.9%)
Sep 2018
-
$2.20M(-9.7%)
$9.00M(+4.4%)
Jun 2018
-
$2.44M(+1.2%)
$8.63M(+8.8%)
Mar 2018
-
$2.41M(+23.6%)
$7.93M(+10.0%)
Dec 2017
$7.21M(+13.6%)
$1.95M(+6.8%)
$7.21M(+1.9%)
Sep 2017
-
$1.83M(+4.8%)
$7.08M(+2.7%)
Jun 2017
-
$1.74M(+3.4%)
$6.89M(+3.2%)
Mar 2017
-
$1.69M(-7.3%)
$6.67M(+5.2%)
Dec 2016
$6.34M(+162.2%)
$1.82M(+11.0%)
$6.34M(+15.9%)
Sep 2016
-
$1.64M(+7.2%)
$5.47M(+26.3%)
Jun 2016
-
$1.53M(+12.7%)
$4.33M(+32.9%)
Mar 2016
-
$1.36M(+43.3%)
$3.26M(+34.7%)
Dec 2015
$2.42M(+73.7%)
$946.60K(+89.5%)
$2.42M(+16.7%)
Sep 2015
-
$499.40K(+9.4%)
$2.07M(+5.3%)
Jun 2015
-
$456.40K(-11.7%)
$1.97M(+30.2%)
Mar 2015
-
$516.80K(-14.0%)
$1.51M(+51.9%)
Dec 2014
$1.39M(+357.9%)
$600.80K(+52.0%)
$996.00K(+152.0%)
Sep 2014
-
$395.20K
$395.20K
Dec 2013
$304.20K
-
-

FAQ

  • What is Axsome Therapeutics annual SGA?
  • What is the all time high annual SGA for Axsome Therapeutics?
  • What is Axsome Therapeutics annual SGA year-on-year change?
  • What is Axsome Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Axsome Therapeutics?
  • What is Axsome Therapeutics quarterly SGA year-on-year change?
  • What is Axsome Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Axsome Therapeutics?
  • What is Axsome Therapeutics TTM SGA year-on-year change?

What is Axsome Therapeutics annual SGA?

The current annual SGA of AXSM is $411.36M

What is the all time high annual SGA for Axsome Therapeutics?

Axsome Therapeutics all-time high annual SGA is $411.36M

What is Axsome Therapeutics annual SGA year-on-year change?

Over the past year, AXSM annual SGA has changed by +$88.24M (+27.31%)

What is Axsome Therapeutics quarterly SGA?

The current quarterly SGA of AXSM is $120.79M

What is the all time high quarterly SGA for Axsome Therapeutics?

Axsome Therapeutics all-time high quarterly SGA is $120.79M

What is Axsome Therapeutics quarterly SGA year-on-year change?

Over the past year, AXSM quarterly SGA has changed by +$21.82M (+22.04%)

What is Axsome Therapeutics TTM SGA?

The current TTM SGA of AXSM is -$4.34B

What is the all time high TTM SGA for Axsome Therapeutics?

Axsome Therapeutics all-time high TTM SGA is -$8.23M

What is Axsome Therapeutics TTM SGA year-on-year change?

Over the past year, AXSM TTM SGA has changed by -$4.68B (-1346.37%)
On this page